Woodlands biopharmaceutical co. to merge with Boston-area startup

Acer Therapeutics, a 3-year-old biotech company developing drugs for ultra-rare diseases, said July 3 that it will go public through a reverse merger with a small Houston-area company.

Cambridge, Massachusetts-based Acer said it would merge with The Woodlands-based Opexa Therapeutics (Nasdaq: OPXA). Shares of the combined company — which will retain Acer’s name and Kendall Square headquarters — will be traded under the ticker “ACER.”

Opexa laid off all but two of its 20 employees after…

Woodlands biopharmaceutical co. to merge with Boston-area startup syndicated post

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s